About Us
Therapeutic Areas
Innovation and Research
Responsibility
Partnering
Professionals
News & More
Berlin Chemie News
Berlin Chemie News Archive
Menarini Group News Archive
Menarini Group News
2024
2023
Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC)
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer
Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San Antonio Breast Cancer Symposium and on ELZONRIS® (tagraxofusp-erzs) at the 65th American Society of Hematology
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
The 2023 Season gets underway for the Volpi Rosse Menarini Wheelchair Basketball Team
European Commission Approves Menarini Group’s ORSERDU<sup>®</sup> (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
The Menarini Group Announces ELZONRIS® (Tagraxofusp) Designated as an Orphan Drug for BPDCN by Japanese Ministry of Health, Labor and Welfare
Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer
Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole
Fair Play Menarini International Awards, excitement is building for the awards ceremony after the “The Champions Tell their Stories”
Great news at the Fair Play Menarini International Awards, tennis player Francesca Schiavone among the winners of the 2023 edition
Fair Play Menarini International Awards, the 2023 edition starts with the talk show “The Champions tell their Stories” in Piazza della Signoria, Florence
Fair Play Menarini International Awards, young swimmer Gianluca Gensini wins the ‘Fiamme Gialle’ special “Studio and Sport” award
Fair Play Menarini International Awards announces the winners of the XXVII edition at CONI
Menarini Group Shares NEXPOVIO® (selinexor) Subgroup Data from BOSTON trial at the European Hematology Association Congress, Highlighting Clinical Potential in Relapsed/Refractory Multiple Myeloma
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU<sup>®</sup> (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
Botticelli, the inquietude and the beauty
Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting
Birth rate emergency, younger generations say: “It’s not just an issue of economic stability”
The doors of Europe open wide for the Volpi Rosse Menarini
Menarini announces an exclusive distribution agreement for Boditech’s AFIAS-10 system
The Dates of the XXVII Edition of the International Fair Play Menarini Awards
Neoplasia a Cellule Dendritiche Plasmacitoidi Blastiche: Aifa approva Tagraxofusp prima e unica terapia contro tumore del sangue raro e aggressivo
Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO<sup>®</sup> (selinexor)
Menarini Group are with the Turkish and Syrian populations
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU™ (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations
2022
Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination
Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH<sup>®</sup> System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early
Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS)
Lost childhood: a 'tight-knit' network to combat abuse and distress
Le Volpi Rosse Menarini continuano la loro avventura in Serie A
QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis
Giorgione: Maestro di mistero, tra Rinascimento e modernità. Domani a Venezia la presentazione del volume d'arte di Menarini dedicato all'artista
Nasce ON RADAR il laboratorio di pensieri, idee, dialogo
Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer
Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer
ATGC Co., Ltd. License Agreement Grants RELIFE S.r.l. Exclusive Rights to Register, Promote, Distribute, and Market the Novel Botulinum Toxin Type A (ATGC-100) in Europe and the United Kingdom.
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination
Karyopharm and Menarini Receive Full Marketing Authorisation from the European Commission for NEXPOVIO<sup>®</sup> (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award
Premio Internazionale Fair Play Menarini: dopo “I campioni si raccontano” la cena di gala in attesa della cerimonia di premiazione
Il XXVI Premio Internazionale Fair Play Menarini debutta a Firenze, “I campioni si raccontano” in diretta tv dal Salone dei Cinquecento
Il Premio Internazionale Fair Play Menarini arriva a Firenze, presentata la XXVI edizione a Palazzo Vecchio
NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe
The XXVI Fair Play Menarini International Award opens with a press conference at CONI
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
Premio Internazionale Fair Play Menarini, assegnato il Premio speciale Fiamme Gialle “Studio e sport”
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Menarini inaugurates new regional headquarters in Dubai, UAE
Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO<sup>®</sup> (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma
Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology
Berlin-Chemie Menarini’s position in Ukraine
Raffaello, maestro di armonia e difensore dei beni culturali protagonista del volume d’arte di Menarini
MENARINI DIAGNOSTICS DETECTS ALL COVID VARIANTS
Conversations with Nobel Prize Winners: The Fondazione Menarini launches their “Dialogs Beyond Borders” series
Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant
2021
2020
2019
2018
2017
2016
2015
2014
2013
Florence - September 11, 2013 - One cell in one billion: the new Italian technology for attacking cancer
Florence, 16th July 2013
Mountain view, calif., July 9, 2013 - Vivus announces avanafil partnership with Menarini
04/07/2013 - Le premiazioni della XVII edizione del Premio “FAIR PLAY” Menarini
18/06/2013 - MENARINI GROUP announces agreement with GILEAD SCIENCES
Florence, 18/06/2013
Rome, 14th June, 2013
Rome, 12th June, 2013
Florence, 6th June, 2013
Florence, 29th May 2013
Florence, 22nd April, 2013
Florence, 11st April, 2013
Menarini a Venezia: la monografia di Tintoretto ammirando la Scuola Grande di San Rocco
Venezia, 24th March 2013 - TINTORETTO
Florence, February 18, 2013 - New Board of Directors appointed at Menarini Industrie Farmaceutiche Riunite, parent company of the Menarini Group
Florence, 4th February 2013
2012
Florence, 13th December 2012
Florence, 6th December 2012
Menarini Press Release - Florence, 13th November 2012
Menarini Press Release - 29th October 2012
Florence, 30th September 2012
Florence, 26th September 2012
Studio Iris 2 against irritable bowel sindrome
Florence, 3rd September 2012
26th July, 2012
Florence, 17th July, 2012
Florence, 9th July, 2012
Berlin, 5th June, 2012
Morrisville, N.C. and Florence, Italy, May 14, 2012 - NEWS RELEASE
Tokyo, Japan / Florence, Italy, April 11, 2012 - NEWS RELEASE
Novalac - Milk for infants
Almirall and Menarini sign a licence agreement and commercial alliance for Aclidinium in the majority of European member states and a number of non-EU
The Menarini Group gets the "Florence" clinical trials underway
Menarini receives "Fiorino solidale" for thr P.I.T.A. project
Florence, February 9th 2012
January 20th 2012
Florence - January 19th 2012
2011
Florence, 29th November 2011
L'Aquila - 28th November 2011: 125th Anniversary Menarini Group - Event dedicated to 'Pharmaceutical Manufacturing '
L’Aquila, November 28th, 2011
Singapore – Florence 15th November 2011: Menarini succeeds in bid for Invida Group
13th October, 2011
Florence, 30th September 2011
Sustenium Plus "Energizes" the Major League Championship
Press Release Menarini Group 19/09/2011
Palazzo Vecchio, Florence 16th September, 2011. MENARINI BABY: the new company crèche to be built with working mothers in mind
An important innovation for people with diabetes, thanks to Menarini research
Denial of article published in "Il mondo"
21st July 2011x
Peschiera Borromeo, 12th July 2011
Gaslini and Menarini diagnostics inaugurate the first mobile medical laboratory for children
The mimosa study: expectations blighted, sense of pride remains high
Wednesday, 25th May 2011
Presentation of the volume dedicated to ‘Bronzino’ to be held in Palazzo Barberini under the auspices of the Menarini Group
Enthusiasm at Menarini L’Aquila
MENARINI WATERPOLO - Menarini becomes the new Title Sponsor of the female water polo team Fiorentina Waterpolo
Menarini research: today’s value, tomorrow’s challenges
Tomorrow in Florence, the convention organised to celebrate the Menarini Group’s 125th anniversary
Major league SUSTENIUM is born
January 2011
2010
2009
Media Library
Kongresse & Veranstaltungen
Fair Play Menarini International Award
Menarini Pills of Art
Careers
Contact Us
Data Privacy
Terms and Conditions
Report a side effect
Quality Requirements API / EXC
Liefer und Rahmenbedinungen
Cookies-Settings
Imprint
Disclaimer
Sitemap
Mandatory Information for Emails
CE-Zertifikate und Konformitätsbescheinigungen (DoC)
Transparency
Search
Data privacy information and netiquette for Social Media
